Pamela J. Cramer - Net Worth and Insider Trading
Pamela J. Cramer Net Worth
The estimated net worth of Pamela J. Cramer is at least $738,855 dollars as of 2024-11-05. Pamela J. Cramer is the Chief Human Resources Officer of Rhythm Pharmaceuticals Inc and owns about 13,500 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $738,855. Details can be seen in Pamela J. Cramer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pamela J. Cramer has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pamela J. Cramer
Pamela J. Cramer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pamela J. Cramer owns 1 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) .
Click here to see the complete history of Pamela J. Cramer’s form 4 insider trades.
Insider Ownership Summary of Pamela J. Cramer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-09-09 | Chief Human Resources Officer |
Pamela J. Cramer Latest Holdings Summary
Pamela J. Cramer currently owns a total of 1 stock. Pamela J. Cramer owns 13,500 shares of Rhythm Pharmaceuticals Inc (RYTM) as of September 9, 2024, with a value of $738,855.
Latest Holdings of Pamela J. Cramer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-09-09 | 13,500 | 54.73 | 738,855 |
Holding Weightings of Pamela J. Cramer
Pamela J. Cramer Form 4 Trading Tracker
According to the SEC Form 4 filings, Pamela J. Cramer has made a total of 12 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 4,099 shares on September 9, 2024, which brought Pamela J. Cramer around $205,073.
Insider Trading History of Pamela J. Cramer
- 1
Pamela J. Cramer Trading Performance
Pamela J. Cramer Ownership Network
Ownership Network List of Pamela J. Cramer
Ownership Network Relation of Pamela J. Cramer
Pamela J. Cramer Owned Company Details
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Pamela J. Cramer is the Chief Human Resources Officer of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Technical Officer Joseph Shulman , Corporate Controller & CAO Christopher Paul German , and EVP & Head of North America Jennifer Chien .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Pamela J. Cramer made 8 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 75,787. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 69,049 shares made by Hunter C Smith .
In summary, during the past 3 months, insiders sold 174,805 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 174,805 shares. During the past 18 months, 582,666 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 582,666 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
Pamela J. Cramer Mailing Address
Above is the net worth, insider trading, and ownership report for Pamela J. Cramer. You might contact Pamela J. Cramer via mailing address: C/o Rhythm Pharmaceuticals, 222 Berkeley Street, Suite 1200, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
